Zymeworks (ZYME) Other Operating Expenses (2022 - 2026)
Zymeworks recorded quarterly Other Operating Expenses of $765000.0 in Q1 2026, down 71.38% quarter-over-quarter from $2.7 million in Q4 2025, and down 77.97% year-over-year from $3.5 million in Q1 2025.
Zymeworks' Other Operating Expenses history runs 5 years deep, the most recent figure standing at $765000.0 for Q1 2026.
- In Q1 2026, Other Operating Expenses fell 77.97% year-over-year to $765000.0; the TTM figure through Mar 2026 stood at $10.1 million (down 43.17% YoY), while the FY2025 annual figure was $12.8 million, down 37.58% from the prior year.
- Other Operating Expenses came in at $765000.0 for Q1 2026 at Zymeworks, down from $2.7 million in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of $6.2 million in Q1 2024 to a low of -$13000.0 in Q1 2022.
- A 5-year average of $3.4 million and a median of $3.8 million in 2025 frame the typical range for Other Operating Expenses.
- Across the five-year window, Other Operating Expenses soared 33315.38% in 2023 and slumped 77.97% in 2026, its largest moves.
- Zymeworks' Other Operating Expenses stood at $1.0 million in 2022, then soared by 305.09% to $4.2 million in 2023, then climbed by 4.96% to $4.4 million in 2024, then sank by 39.61% to $2.7 million in 2025, then sank by 71.38% to $765000.0 in 2026.
- According to Business Quant data, Other Operating Expenses over the past three periods registered $765000.0, $2.7 million, and $3.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Zymeworks | 1.84 Bn | 1.47 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 765,000.00 |
| Dec 31, 2025 | 2.67 Mn |
| Sep 30, 2025 | 3.84 Mn |
| Jun 30, 2025 | 2.81 Mn |
| Mar 31, 2025 | 3.47 Mn |
| Dec 31, 2024 | 4.43 Mn |
| Sep 30, 2024 | 4.58 Mn |
| Jun 30, 2024 | 5.27 Mn |
| Mar 31, 2024 | 6.22 Mn |
| Dec 31, 2023 | 4.22 Mn |
| Sep 30, 2023 | 5.66 Mn |
| Jun 30, 2023 | 4.62 Mn |
| Mar 31, 2023 | 4.32 Mn |
| Dec 31, 2022 | 1.04 Mn |
| Sep 30, 2022 | 2.48 Mn |
| Jun 30, 2022 | 1.20 Mn |
| Mar 31, 2022 | -13,000.00 |